Sfoglia per Autore
What is the Role of Fluoroquinolones in Intensive Care?
2003 Viale P.; Pea F.
Antimicrobial agents in elective surgery: prophylaxis or "early therapy"?
2003 Pea, F; Viale, P; Furlanut, M I
Teicoplanin in patients with acute leukaemia and febrile neutropenia: A special population benefiting from higher dosages
2004 Pea F.; Viale P.; Candoni A.; Pavan F.; Pagani L.; Damiani D.; Casini M.; Furlanut M.
Incidence and risk factors associated with pressure ulcers among patients with HIV infection
2004 Nicastri E; Viale P; Lyder CH; Cristini F; Martini L; Preziosi G; Dodi F; Irato L; Pan A; Petrosillo N
Antifungal descalation or escalation therapy?
2004 Viale P
Linezolid disposition after standard dosages in critically ill patients undergoing continuous venovenous hemofiltration: A report of 2 cases
2004 Pea F.; Viale P.; Lugano M.; Pavan F.; Scudeller L.; Rocca G.D.; Furlanut M.
Liver transplantation from old donors into HCV and non-HCV recipients.
2004 Baccarani U; Adani GL; Toniutto P; Sainz M; Lorenzin D; Viale P; Ramacciato G; Risaliti A; Bresadola F
Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: Helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure
2005 Pea F.; Viale P.; Damiani D.; Pavan F.; Cristini F.; Fanin R.; Furlanut M.
Endovascular treatment of aortic pseudoaneurysm after liver transplantation.
2005 Adani GL; Baccarani U; Gasparini D; Sponza M; Sainz-Barriga M; Lorenzin D; Viale P; Risaliti A; Bresadola F
Antimicrobial therapy in critically ill patients: A review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability
2005 Pea F.; Viale P.; Furlanut M.
Nosocomial pulmonary infections in HIV-positive patients.
2005 Petrosillo N; Nicastri E; Viale P
Hyperlactacidemia potentially due to linezolid overexposure in a liver transplant recipient [4]
2006 Pea F.; Scudeller L.; Lugano M.; Baccarani U.; Pavan F.; Tavio M.; Furlanut M.; Della Rocca G.; Bresadola F.; Viale P.
The effect of multifactorial, multidisciplinary educational interventions on appropriate use of teicoplanin
2006 Pea F.; Viale P.; Pavan F.; Tavio M.; Poz D.; Beltrame A.; Furlanut M.
Which reliable pharmacodynamic breakpoint should be advised for ciprofloxacin monotherapy in the hospital setting? A TDM-based retrospective perspective
2006 Pea F.; Poz D.; Viale P.; Pavan F.; Furlanut M.
Pharmacokinetic-pharmacodynamic aspects of antimicrobial prophylaxis with teicoplanin in patients undergoing major vascular surgery
2006 Pea F.; Furlanut M.; Stellini R.; Bonardelli S.; Signorini L.; Pavan F.; Matheis A.; Portolani N.; Lorenzotti S.; Giulini S.M.; Viale P.; Carosi G.
De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
2006 Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale P; Bresadola F.
The antimicrobial therapy puzzle: Could pharmacokinetic-pharmacodynamic relationships be helpful in addressing the issue of appropriate pneumonia treatment in critically ill patients?
2006 Pea F.; Viale P.
Comparison of clinical and pathological staging and long-term results of liver transplantation for hepatocellular carcinoma in a single transplant center.
2006 Baccarani U; Adani GL; Avellini C; Lorenzin D; Currò G; Beltrami A; Pasqualucci A; Bresadola V; Risaliti A; Viale P; Beltrami CA; Bresadola F
Vascular catheter-associated infections: a microbiological and therapeutic update.
2006 Viale P; Stefani S
African trypanosomiasis gambiense, Italy.
2006 Bisoffi Z; Beltrame A; Monteiro G; Arzese A; Marocco S; Rorato G; Anselmi M; Viale P
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile